FDA Import Refusal 231-9927049-2/11/2 — Celgene International Sarl
The FDA refused shipment 231-9927049-2/11/2 from Celgene International Sarl (Switzerland) on October 14, 2021. The refused product falls under Drugs and Biologics — REVLIMID. Cited charge: 75 This firm has 2 other import refusals on record.
Refusal Details
- Date
- October 14, 2021
- Country
- Switzerland
- Product Category
- Drugs and Biologics
- Product Code
- 61CIE03 REVLIMID
- Charges
- 75